NFKB1 and ovarian cancer: Similar to this, in ovarian cancer cells, fatty acid synthesis and the phosphorylation of the NF-κB signaling pathway are inhibited by blocking FASN and carnitine palmitoyl transferase 1A (CPT1A) activity through miR-33b’s targeting of growth factor β-activated kinase 1 (TAK1), which, in turn, prevents the peritoneal metastasis of ovarian cancer [146].